Clinical trials sponsored by SOLTI Breast Cancer Research Group

Phase breakdown

Conditions studied

Recruiting trials led by SOLTI Breast Cancer Research Group

• Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer
  NCT05982093 · Phase: Phase 2 · Ages: 35 Years and older · Sex: Female · 15 locations
• Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)
  NCT05885009 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location
• HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan
  NCT06236269 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain
  NCT06991946 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is SOLTI Breast Cancer Research Group recruiting for?

SOLTI Breast Cancer Research Group is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.